For AD, P(AD) correlated with Aβ, tau and FDG PET biomarkers across the NACC and ADNI cohorts, indicating statistically significant differences between biomarker-negative and positive groups (P < 0.0001). This evidence concerns the gene MAPT and Alzheimer disease.